New treatment directions for patients with myeloma

Dr Pieter Sonneveld

At the 20th Congress of the European Hematology Association (EHA), Dr Pieter Sonneveld, of the Erasmus MC University Cancer Institute, Rotterdam, the Netherlands, considers some of the opportunities and challenges of emerging approaches, which are in active clinical trials, that are aiming to improve treatment outcomes in patients with myeloma. Supportive care is highlighted as an area of importance.

See all videos from: